Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

26 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Toll-like receptor 7 protects from atherosclerosis by constraining "inflammatory" macrophage activation.
Salagianni M, Galani IE, Lundberg AM, Davos CH, Varela A, Gavriil A, Lyytikäinen LP, Lehtimäki T, Sigala F, Folkersen L, Gorgoulis V, Lenglet S, Montecucco F, Mach F, Hedin U, Hansson GK, Monaco C, Andreakos E. Salagianni M, et al. Among authors: galani ie. Circulation. 2012 Aug 21;126(8):952-62. doi: 10.1161/CIRCULATIONAHA.111.067678. Epub 2012 Jul 11. Circulation. 2012. PMID: 22787112
CXCL13 production in B cells via Toll-like receptor/lymphotoxin receptor signaling is involved in lymphoid neogenesis in chronic obstructive pulmonary disease.
Litsiou E, Semitekolou M, Galani IE, Morianos I, Tsoutsa A, Kara P, Rontogianni D, Bellenis I, Konstantinou M, Potaris K, Andreakos E, Sideras P, Zakynthinos S, Tsoumakidou M. Litsiou E, et al. Among authors: galani ie. Am J Respir Crit Care Med. 2013 Jun 1;187(11):1194-202. doi: 10.1164/rccm.201208-1543OC. Am J Respir Crit Care Med. 2013. PMID: 23525932
Reply: CXCL13 in tertiary lymphoid tissues: sites of production are different from sites of functional localization.
Litsiou E, Semitekolou M, Galani I, Morianos I, Tsoutsa A, Kara P, Rontogianni D, Bellenis I, Konstantinou M, Potaris K, Andreakos E, Sideras P, Zakynthinos S, Tsoumakidou M. Litsiou E, et al. Am J Respir Crit Care Med. 2014 Feb 1;189(3):370-1. doi: 10.1164/rccm.201308-1519LE. Am J Respir Crit Care Med. 2014. PMID: 24484346 No abstract available.
TFEB signaling attenuates NLRP3-driven inflammatory responses in severe asthma.
Theofani E, Semitekolou M, Samitas K, Mais A, Galani IE, Triantafyllia V, Lama J, Morianos I, Stavropoulos A, Jeong SJ, Andreakos E, Razani B, Rovina N, Xanthou G. Theofani E, et al. Among authors: galani ie. Allergy. 2022 Jul;77(7):2131-2146. doi: 10.1111/all.15221. Epub 2022 Jan 25. Allergy. 2022. PMID: 35038351
26 results